Summary Serine proteases, such as a-chymotrypsin or elastase, caused an aggregation of rat ascites tumour cell lines, AH-130, AH-109A and YS, in a protein free medium which preserved the cell viability. This aggregation, which was monitored spectrophotometrically, was dependent upon the protease activities and was resistant to treatment with either a calcium chelating reagent (EDTA) al., 1973;Liotta et al., 1980;Sloane et al., 1982;Wang et al., 1980). It has also been shown that an important event in blood-borne metastasis is the intercellular adhesion and aggregation of circulating tumour cells (Nicolson & Winkelhake, 1975). The aggregated state of tumour cells in the microcirculation may be favourable to lodgement in distant organs. In this sense, the role of the plasma clotting system (Kinjo, 1978) or platelets (Hara et al., 1980) in blood-borne metastasis has been emphasised with special reference to the formation of floating or plugged masses of tumour cells.In our preliminary experiments, serine proteases such as a-chymotrypsin or elastase caused an aggregation of rat ascites tumour cell lines, AH-130, AH-109A and YS, without any appreciable change in cell viability. In the present study, we have examined a potential augmenting effect of proteaseinduced cell aggregation in vitro and in vivo on blood-borne metastasis using the lung-colonisation model with rat ascites tumour cells. In addition, we also examined the effectiveness of DNase I treatment (which prevented the protease-induced cell aggregation) on blood-borne metastasis in the lung.
Materials and methods
AnimalsFemale Donryu rats weighing 130-180 g were generally used in this study. These rats received a standard rat pellet diet and tap water ad lib.
ReagentsCrystallised bovine pancreatic a-chymotrypsin, elastase, neuraminidase, bovine muscular actin, bovine pancreatic DNase I and calf thymus DNA were purchased from Sigma Chemical Co. (St Louis, MO, USA). Chymostatin and elastatinal were purchased from Peptide Institute Inc. (Osaka, Japan). Hanks' balanced salt solution (HBSS) (without phenol red) was purchased from Nissui Pharm. Co. (Tokyo, Japan), HBSS (without Ca2 , Mg2 + and phenol red) from Gibco (Grand Island, NY, USA). An assay kit for lactate dehydrogenase (LDH) was obtained from Shinotest Laboratories (Kanagawa, Japan).The DNase I was further purified using a high performance liquid chromatography system (LKB) with a TSK gel 3,000 SW gel permeation column (Tosoh). The final preparation was pure as judged by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate with or without 1% P-mercaptoethanol.